8-K: QT Imaging and NXC Imaging Amend Distribution Agreement, Setting Minimum Order Quantities

QT Imaging and NXC Imaging have amended their distribution agreement, introducing minimum order quantities and extending the term to December 31, 2026.

Summary

• QT Imaging and NXC Imaging have entered into an Amended and Restated Distribution Agreement, modifying their original agreement from June 10, 2024.
• The amended agreement includes a condition that a Manufacturing Agreement between QT Imaging and Canon Medical Systems Corporation must be in place by December 30, 2024, for NXC to maintain exclusivity as a reseller.
• The agreement introduces minimum order quantities (MOQs) for NXC, detailed in Exhibit C, which are binding unless QT Imaging cannot meet the required manufacturing and delivery volumes.
• NXC is required to provide a 12-month forecast of anticipated purchases each quarter, with specific MOQs for 2025 and 2026.
• If NXC fails to meet the MOQs, QT Imaging can invoice NXC for the difference between the equipment purchased and the MOQs.
• The agreement removes the cap on NXC's markup, allowing them to set resale prices at their discretion.
• Payment terms require NXC to pay invoices within 30 days of equipment shipment.
• QT Imaging is obligated to provide technical support and spare parts for at least five years after equipment installation.
• The agreement extends the term to December 31, 2026, unless terminated earlier or extended by mutual agreement.

Sentiment

Score: 7

Explanation: The document indicates a positive step for QT Imaging with a structured distribution agreement and minimum order quantities, but there are some risks associated with the manufacturing agreement and NXC's ability to meet the MOQs.

Positives

• The removal of the markup cap allows NXC greater flexibility in pricing and potentially higher profits.
• The extension of the agreement to 2026 provides long-term stability for both parties.
• The agreement ensures continued technical support and spare parts availability for at least five years after installation, which is beneficial for customers.
• The minimum order quantities provide a predictable revenue stream for QT Imaging.

Negatives

• NXC is obligated to meet minimum order quantities, which could be a risk if demand is lower than expected.
• QT Imaging may invoice NXC for the difference if MOQs are not met, potentially impacting NXC's cash flow.
• The agreement is contingent on a Manufacturing Agreement with Canon Medical Systems Corporation being finalized by December 30, 2024, creating uncertainty.

Risks

• The Manufacturing Agreement with Canon Medical Systems Corporation must be finalized by December 30, 2024, or the exclusivity of the agreement may be impacted.
• NXC's ability to meet the minimum order quantities is dependent on market demand and their sales performance.
• QT Imaging's ability to fulfill the manufacturing and delivery volumes required for NXC to meet the MOQs is a potential risk.
• Changes in pricing by QT Imaging could impact NXC's profitability.

Future Outlook

The agreement extends the partnership between QT Imaging and NXC Imaging through December 31, 2026, with the potential for further extension by mutual agreement. The success of the agreement is contingent on the finalization of the Manufacturing Agreement with Canon Medical Systems Corporation by December 30, 2024.

Management Comments

• The document does not contain any direct quotes from management, but the agreement itself reflects the strategic direction of the company.

Industry Context

This agreement is in the medical imaging industry, where distribution partnerships are common for reaching a wider customer base. The agreement with NXC, a subsidiary of Canon Medical Systems, indicates a strategic move to leverage an established distribution network. The inclusion of minimum order quantities suggests a push for increased sales volume and market penetration.

Comparison to Industry Standards

• Distribution agreements in the medical device industry often include exclusivity clauses, similar to the one granted to NXC for the U.S. and its territories.
• Minimum order quantities are a common practice to ensure a certain level of sales volume for the manufacturer, similar to agreements between GE Healthcare and its distributors.
• The 5-year after-sales service commitment is in line with industry standards for medical equipment, comparable to service agreements offered by Siemens Healthineers.
• The pricing structure, with a base price and options, is typical for medical imaging equipment, similar to pricing models used by Philips Healthcare.
• The agreement's terms, including payment terms and warranty periods, are generally consistent with industry norms for medical device distribution.

Stakeholder Impact

• Shareholders: The agreement provides a structured sales channel and potential revenue stream, which is positive for shareholders.
• Employees: The agreement may lead to increased production and sales, potentially impacting employment.
• Customers: The agreement ensures continued technical support and spare parts availability, which is beneficial for customers.
• Suppliers: The agreement may lead to increased demand for components and parts, impacting suppliers.
• Creditors: The agreement provides a predictable revenue stream, which is positive for creditors.

Next Steps

• Finalization of the Manufacturing Agreement between QT Imaging and Canon Medical Systems Corporation by December 30, 2024.
• NXC to provide quarterly forecasts of anticipated purchases.
• NXC to begin placing orders in accordance with the minimum order quantities.
• QT Imaging to ensure manufacturing and delivery capabilities to meet NXC's orders.
• Implementation of technical support and spare parts provision for NXC's customers.

Key Dates

Keywords

Distribution Agreement, Minimum Order Quantities, Reseller, Medical Equipment, NXC Imaging, QT Imaging, Canon Medical Systems, Manufacturing Agreement, Exclusive Reseller, Technical Support